FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

111134000: oxétacaïne (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2153813010 Oxetacaine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2154820013 Oxethazaine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3482733018 Oxetacaine (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
496261000241119 oxétacaïne (substance) fr Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
830131000172113 oxétacaïne fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Oxethazaine est un(e) (attribut) Amide type local anesthetic (substance) false Inferred relationship Some
Oxethazaine est un(e) (attribut) Amide type local anesthetic (product) false Inferred relationship Some
Oxethazaine est un(e) (attribut) Amide and/or amide derivative (substance) true Inferred relationship Some
Oxethazaine est un(e) (attribut) Local anesthetic (substance) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing only aluminium oxide and magnesium hydroxide and oxetacaine (medicinal product) a pour principe actif (attribut) True Oxethazaine Inferred relationship Some 1
Product containing only oxetacaine (medicinal product) a pour principe actif (attribut) True Oxethazaine Inferred relationship Some 1
Product containing precisely aluminium hydroxide 58.2 milligram/milliliter and magnesium hydroxide 19.6 milligram/milliliter and oxetacaine 2 milligram/1 milliliter conventional release oral suspension (clinical drug) Has precise active ingredient True Oxethazaine Inferred relationship Some 1
Product containing precisely aluminium hydroxide 58.2 milligram/milliliter and magnesium hydroxide 19.6 milligram/milliliter and oxetacaine 2 milligram/1 milliliter conventional release oral suspension (clinical drug) Has basis of strength substance (attribute) True Oxethazaine Inferred relationship Some 1
Aluminum hydroxide- and magnesium hydroxide- and oxethazaine-containing product in oral dose form a pour principe actif (attribut) True Oxethazaine Inferred relationship Some 1
Aluminum hydroxide and magnesium hydroxide and oxethazaine only product in oral dose form a pour principe actif (attribut) True Oxethazaine Inferred relationship Some 1
Product containing only aluminium hydroxide and magnesium hydroxide and oxetacaine (medicinal product) a pour principe actif (attribut) True Oxethazaine Inferred relationship Some 1
Aluminum hydroxide- and magnesium hydroxide- and oxethazaine-containing product a pour principe actif (attribut) True Oxethazaine Inferred relationship Some 1
Product containing aluminium oxide and magnesium hydroxide and oxetacaine (medicinal product) a pour principe actif (attribut) True Oxethazaine Inferred relationship Some 1
Product containing oxetacaine (medicinal product) a pour principe actif (attribut) True Oxethazaine Inferred relationship Some 1

This concept is not in any reference sets

Back to Start